Published in Sven Tandlak Tidskr on August 01, 1972
Molecular pathology of haemophilia B. EMBO J (1989) 2.74
Thromboembolic disease--critical evaluation of laboratory investigation. Thromb Haemost (1992) 1.93
Fibrinolytic activity of human veins. Lancet (1967) 1.91
AHF related protein in clinical praxis. Scand J Haematol (1974) 1.78
Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. Acta Chir Scand (1972) 1.74
The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. Nucleic Acids Res (1990) 1.64
Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol) (1980) 1.64
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med (1999) 1.61
A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res (1980) 1.59
Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate. Lancet (1990) 1.53
Intrauterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand (1975) 1.51
A nascent secretory protein may traverse the ribosome/endoplasmic reticulum translocase complex as an extended chain. J Biol Chem (1996) 1.51
Determination of plasminogen in clots and thrombi. Thromb Diath Haemorrh (1966) 1.48
Coagulation and fibrinolytic studies during pregnancy. Acta Obstet Gynecol Scand (1967) 1.48
Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol (1975) 1.47
Haemophilia prophylaxis in Sweden. Acta Paediatr Scand (1976) 1.46
Haemophilia prophylaxis in young patients--a long-term follow-up. J Intern Med (1997) 1.44
Intravascular coagulation and acute renal failure in a child with mycoplasma infection. Acta Med Scand (1971) 1.44
[Threatened future of plasma products. Who is responsible?]. Lakartidningen (1996) 1.39
The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology (1998) 1.30
Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haematol (1965) 1.29
Two genetic variants of von Willebrand's disease. N Engl J Med (1973) 1.25
[Risk of thromboembolism with oral contraceptives]. Lakartidningen (1967) 1.23
Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC). J Clin Invest (1982) 1.23
Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J (Clin Res Ed) (1985) 1.19
Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. N Engl J Med (1983) 1.18
Coagulation and fibrinolytic studies during use of gestagens. Acta Obstet Gynecol Scand (1967) 1.14
Catheter material and blood coagulation studies in vitro. Scand J Haematol (1969) 1.13
Fibrinolysis in newborns. Acta Paediatr Scand (1970) 1.12
New aspects of the pathogenesis of thrombo-embolism. Prog Surg (1973) 1.11
Fibrin degradation products and ovarian tumours. Br Med J (1971) 1.08
Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg. Acta Chir Scand (1970) 1.08
Thrombosis and oral contraceptives: possible predisposition. Br Med J (1973) 1.07
Coagulation and fibrinolytic studies during continuous use of low dose gestagen. Acta Endocrinol (Copenh) (1970) 1.07
Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX. Scand J Haematol (1976) 1.06
Shelf-life of bank blood and stored plasma with special reference to coagulation factors. Transfusion (1983) 1.06
"Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms. Acta Chir Scand (1972) 1.05
Binding of delta-1-tetrahydrocannabinol to human plasma proteins. Biochem Pharmacol (1970) 1.05
Value of streptokinase and heparin in treatment of acute deep venous thrombosis. A coded investigation. Acta Chir Scand (1968) 1.04
Genetic variants of von Willebrand's disease. Br Med J (1972) 1.03
Our experience in Sweden with prophylaxis on haemophilia. Bibl Haematol (1970) 1.03
Inhibition of platelet prothrombinase activity by a lupus anticoagulant. Blood (1983) 1.02
Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study. Acta Neurol Scand (1972) 1.02
Coagulation and fibrinolysis in chronic panniculitis. Acta Derm Venereol (1970) 1.02
Thrombosis in the superior mesenteric and portal veins: report of a case treated with thrombectomy. Surgery (1974) 1.02
Factor XIII (fibrin stabilising factor) in Henoch-Schönlein's purpura. Acta Paediatr Scand (1977) 1.02
An HphI-polymorphism in exon 28 of the von Willebrand factor gene, and its frequency among patients with various forms of von Willebrand's disease. Br J Haematol (1991) 1.02
Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A. Scand J Haematol (1974) 1.02
The role of beta-1-adrenoceptors in the renin release response to graded renal sympathetic nerve stimulation. Pflugers Arch (1980) 1.01
Pregnancy and parturition in a patient with severe Glanzmann's thrombasthenia. Scand J Haematol (1981) 1.01
Serum fibrin-fibrinogen degradation products in acute myocardial infarction. Lancet (1972) 1.00
Diagnostic symptoms of severe and moderate haemophilia A and B. A survey of 140 cases. Acta Paediatr Scand (1990) 1.00
"Fibrinolytic capacity" in healthy volunteers at different ages as studied by standardized venous occlusion of arms and legs. Acta Med Scand (1972) 0.99
Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems. Scand J Haematol (1970) 0.99
Fibrinolytic activity of human veins in arms and legs. Thromb Diath Haemorrh (1968) 0.99
Autologous blood transfusion in revision hip arthroplasty. A prospective, controlled study of 30 patients. Acta Orthop Scand (1992) 0.98
Two factor IX mutations in the family of an isolated haemophilia B patient: direct carrier diagnosis by amplification mismatch detection (AMD). Hum Genet (1990) 0.98
Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity. Br J Haematol (1991) 0.98
Coagulation studies in different types of myeloma. Acta Med Scand Suppl (1966) 0.97
Diabetic retinopathy and the fibrinolytic system. Diabetes (1975) 0.97
Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII. Acta Med Scand (1972) 0.96
Origin of mutation in sporadic cases of haemophilia-B. Eur J Haematol (1992) 0.96
Occurrence of arteriosclerosis in von Willebrand's disease. Acta Med Scand (1966) 0.96
von Willebrand's disease. Eur J Haematol (1992) 0.96
Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage. Acta Neurol Scand (1973) 0.95
Effects of concentration and volume on nasal bioavailability and biological response to desmopressin. J Pharm Sci (1988) 0.95
Cancer, F.D.P., and radiotherapy. Br Med J (1972) 0.94
Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies. Proc Natl Acad Sci U S A (1986) 0.94
Urokinase inhibitors in serum in a clinical series. Acta Med Scand (1971) 0.93
Elimination of tritium-labelled cannabinols in the rat with special reference to the development of tests for the identification of cannabis users. Biochem Pharmacol (1969) 0.93
Coagulation, fibrinolysis and venous thrombosis. Triangle (1977) 0.93
Gastric fibrinolysis. Thromb Diath Haemorrh (1975) 0.93
Immunological characterisation of plasminogen activators in the human vessel wall. J Clin Pathol (1983) 0.92
Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin. J Pharm Sci (1988) 0.92
Technical remarks on the microscopical demonstration of tissue plasminogen activator. Thromb Diath Haemorrh (1972) 0.92
Smoking and fibrinolysis. Circulation (1975) 0.92
Phenformin and ethyloestrenol in recurrent venous thrombosis. Acta Med Scand (1975) 0.91
[Blood loss in Charnley's total hip replacement]. Lakartidningen (1977) 0.91
Hypofibrinogenaemia and massive thrombosis. Acta Med Scand (1966) 0.91
von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma. Blood (1986) 0.90
Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity. Scand J Clin Lab Invest (1970) 0.90
Studies on blood clotting factors in man after massive liver resection. Acta Chir Scand (1967) 0.90
Giant haemangioma with a disorder of coagulation. Acta Paediatr Scand (1971) 0.90
Immunologic studies in haemophilia A. Scand J Haematol (1973) 0.90
Immunoadsorption for removal of inhibitors: update on treatments in Malmö-Lund between 1980 and 1995. Haemophilia (1998) 0.89
A family with thromboembolic disease associated with deficient fibrinolytic activity in vessel wall. Acta Med Scand (1978) 0.89
Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX. Blood (1980) 0.89
Haplotype analysis of identical factor IX mutants using PCR. Thromb Haemost (1992) 0.89
Studies of the blood plasminogen activator induced by 1-desamino-8-D-arginine vasopressin with observations in von Willebrand's disease. Proc Soc Exp Biol Med (1982) 0.89
Circulating anticoagulant against factors XI and XII together with massive spontaneous platelet aggregation. Scand J Haematol (1973) 0.89
Typing of fibrinogen degradation products in urine in various clinical disorders. Scand J Clin Lab Invest (1971) 0.89
Von Willebrand's disease--fifty years old. Acta Med Scand (1977) 0.89
Molecular size distribution of factor VIII in native plasma. Thromb Res (1979) 0.88
Studies on the prolonged bleeding time in von Willebrand's disease. J Lab Clin Med (1976) 0.88
Measurement of antihaemophilic factor A antigen (VII:CAg) with a solid phase immunoradiometric method based on homologous non-haemophilic antibodies. Scand J Haematol (1979) 0.88
Generalized proteolysis in a young woman with Weber-Christian disease (nodular nonsuppurative panniculitis). Scand J Haematol (1975) 0.88
In vivo recovery of factor VIII: a comparison of one-stage and two-stage assay methods. Thromb Haemost (1979) 0.87
Urinary fibrin-fibrinogen degradation products (FDP) and glomerulonephritis. Acta Med Scand (1974) 0.87